Global /Israel /Healthcare /Biotechnology /PLNT

PlantArc Bio Ltd.

PLNT

• TLV: PLNT • Delayed

221ILA 0%

0.7638 USD

As of 5 June 2026, PlantArc Bio Ltd. has a market cap of $2.53M USD, ranking #46606 globally and #617 in Israel. It ranks #4120 in the Healthcare sector, and #811 in the Biotechnology industry.

Global Rank

46606

Country Rank

617

Sector Rank

4120

Industry Rank

811

Key Stats

Market Cap

$2.53MUSD

7.33M ILS

Enterprise Value

-$134.85KUSD

-389.99K ILS

Revenue (TTM)

$1.06MUSD

3.07M ILS

EBITDA (TTM)

-$1.01MUSD

-2.92M ILS

Net Income (TTM)

-$999.31KUSD

-2.89M ILS

EBITDA Margin

-95%

Profit Margin

-94%

PS Ratio

2.4

PB Ratio

1.0

Company Profile

Country (HQ)

Israel

Sector

Healthcare

Industry

Biotechnology

CEO

Dror Shalitin open_in_new

Employees

Founded

2014

Website

plantarcbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0.8%	4.6%	5.7%	-6%	-30%	-22%	-73%	-88%

News

Markets

Exchange	Ticker	Price	Quotes
Tel Aviv Stock Exchange (TLV) MIC: XTAE PRIMARY	PLNT פלנטארק ביו בע''מ Ordinary Shares ISIN: IL0011714040 Shares Out.: Shares Outstanding: 3.316M¹ TV: TradingView: TASE: PLNT SA: Stock Analysis: TLV: PLNT YF: Yahoo Finance: PLNT.TA GF: Google Finance: TLV: PLNT BA: Barron's: PLNT MS: Morningstar: XTAE: PLNT	221 ILA	TV: TradingView: TASE: PLNT SA: Stock Analysis: TLV: PLNT YF: Yahoo Finance: PLNT.TA GF: Google Finance: TLV: PLNT BA: Barron's: PLNT MS: Morningstar: XTAE: PLNT

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PlantArc Bio Ltd.

PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.

Similar Companies

Industry: Biotechnology (Israel)

Name	Market Cap (USD) diff.	PE	Country
Kamada Ltd. NASDAQ: KMDA	$470.55M 18K%	23.3	Israel
Israel Canada Hotels Ltd. TLV: DNA	$332.67M 962.09M ILS 13K%	267.3	Israel
Compugen Ltd. NASDAQ: CGEN	$245.84M 10K%	6.9	Israel
Enlivex Ltd. NASDAQ: ENLV	$190.26M 7K%	0.0	Israel
Kadimastem Ltd. TLV: KDST	$55.69M 161.06M ILS 2K%	-	Israel
Pluri Inc. NASDAQ: PLUR	$34.07M 1K%	-	Israel

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 7M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 6M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 2M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 2M%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 2M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 2M%	37.2	Switzerland

chevron_leftBack